Researcher
Ludo Van Den Bosch
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Responsible
From1 Oct 2018 → Today - Van Den Bosch Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 2002 → 31 Dec 2011
Projects
1 - 10 of 60
- Investigating the pathological mechanisms underlying KIF5A mutations in ALSFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Engineering Functional 3D Neuromuscular Junctions: Investigating Myogenic Stem Cell Differentiation and Integration with iPSC-Derived Motor NeuronsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Investigating fatty acid toxicity in amyotrophic lateral sclerosisFrom1 Oct 2023 → TodayFunding: FWO senior postdoctoral fellowship
- Investigating the therapeutic potential of HDAC6 inhibition in amyotrophic lateral sclerosis (ALS) using human induced pluripotent stem cells (iPSCs).From1 May 2023 → TodayFunding: Other federal public and semi-governmental institutions
- FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and loss-of-support mechanismsFrom19 Apr 2023 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- Creating iPSC-derived 3D human neuromuscular junctions to investigate amyotrophic lateral sclerosis (ALS)From15 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Investigating mechanisms of RNA misprocessing in Amyotrophic Lateral SclerosisFrom8 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Determination and investigation of the therapeutic targets of HDAC6 inhibition in amyotrophic lateral sclerosis (ALS)From1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Creation of a humanized mouse model for demyelinating peripheral neuropathies as a platform for therapeutic testing.From1 Jan 2023 → TodayFunding: BOF - iBOF
- Investigating the role of DNA damage and repair in the selective motor neuron death during amyotrophic lateral sclerosis (ALS)From15 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
171 - 180 of 231
- Rapamycin increases survival in ALS mice lacking mature lymphocytes(2013)
Authors: James Dooley, Philip Van Damme, Adrian Liston, Wim Robberecht, Ludo Van Den Bosch
- Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice(2013)
Authors: Kim Staats, Lawrence Van Helleputte, Robin Lemmens, Philip Van Damme, Adrian Liston, Wim Robberecht, Ludo Van Den Bosch
Pages: 11 - 17 - Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS(2013)
Authors: Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht
Pages: 1783 - 1790 - Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis(2013)
Authors: Annelies Nonneman, Kim Staats, Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht
Pages: 471 - 82 - Aire mediates thymic expression and tolerance of pancreatic antigens via an unconventional transcriptional mechanism(2013)
Authors: Dina Danso-Abeam, Kim Staats, Dean Franckaert, Ludo Van Den Bosch, Adrian Liston, James Dooley
Pages: 75 - 84 - Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis.(2013)
Authors: Kim A Staats, Susann Schönefeldt, Marike Van Rillaer, Annelies Van Hoecke, Philip Van Damme, Wim Robberecht, Adrian Liston, Ludo Van Den Bosch
Pages: 249 - Kinetic chain influences on upper and lower trapezius muscle activation during eight variations of a scapular retraction exercise in overhead athletes(2013)
Authors: Ludo Van Den Bosch
Pages: 65 - 70 - Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis(2013)
Authors: Philip Van Damme, Wim Robberecht, Adrian Liston, Ludo Van Den Bosch
Pages: 249 - 249 - Neuronal overexpression of IP(3) receptor 2 is detrimental in mutant SOD1 mice(2012)
Authors: Kim Staats, Elke Bogaert, Geert Bultynck, Jan Parys, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch
Pages: 210 - 213 - Neuronal overexpression of IP(3) receptor 2 is detrimental in mutant SOD1 mice(2012)
Authors: Kim Staats, Elke Bogaert, Nicole Hersmus, Tom Jaspers, Tomas Luyten, Geert Bultynck, Jan Parys, Chihiro Hisatsune, Katsuhiko Mikoshiba, Philip Van Damme, et al.
Pages: 210 - 213
Patents
1 - 4 of 4